{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:13:13Z","timestamp":1783710793158,"version":"3.55.0"},"reference-count":119,"publisher":"Xia & He Publishing","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,28]]},"DOI":"10.14218\/jcth.2017.00032","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T21:19:28Z","timestamp":1512595168000},"page":"1-9","source":"Crossref","is-referenced-by-count":16,"title":["Autoimmune Hepatitis in the Asia-Pacific Area"],"prefix":"10.14218","volume":"6","author":[{"given":"Qi-Xia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","published-online":{"date-parts":[[2017,12,7]]},"reference":[{"key":"key20171206211924_b1","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.3748\/wjg.14.3292","article-title":"Historical reflections on autoimmune hepatitis","volume":"14","author":"Mackay","year":"2008","journal-title":"World J Gastroenterol"},{"key":"key20171206211924_b2","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: International Autoimmune Hepatitis Group","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"key":"key20171206211924_b3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"key20171206211924_b4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"key20171206211924_b5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.dld.2009.06.013","article-title":"Clinical features of autoimmune hepatitis diagnosed based on simplified criteria of the International Autoimmune Hepatitis Group","volume":"42","author":"Miyake","year":"2010","journal-title":"Dig Liver Dis"},{"key":"key20171206211924_b6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jhep.2010.06.032","article-title":"Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients","volume":"54","author":"Qiu","year":"2011","journal-title":"J Hepatol"},{"key":"key20171206211924_b7","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/hep.22825","article-title":"Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients","volume":"49","author":"Muratori","year":"2009","journal-title":"Hepatology"},{"key":"key20171206211924_b8","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/hep.23042","article-title":"Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease","volume":"50","author":"Yeoman","year":"2009","journal-title":"Hepatology"},{"key":"key20171206211924_b9","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/hep.22513","article-title":"Performance parameters of the diagnostic scoring systems for autoimmune hepatitis","volume":"48","author":"Czaja","year":"2008","journal-title":"Hepatology"},{"key":"key20171206211924_b10","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/jgh.12952","article-title":"Autoimmune hepatitis: East meets west","volume":"30","author":"Yang","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"key20171206211924_b11","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1046\/j.1440-1746.2001.02646.x","article-title":"Autoimmune hepatitis in Singapore: a rare syndrome affecting middle-aged women","volume":"16","author":"Lee","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"key20171206211924_b12","first-page":"602","article-title":"Profiles of autoimmune hepatitis in Brunei Darussalam","volume":"8","author":"Jalihal","year":"2009","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"key20171206211924_b13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1445-5994.2009.02041.x","article-title":"Autoimmune hepatitis in a demographically isolated area of Australia","volume":"40","author":"Haider","year":"2010","journal-title":"Intern Med J"},{"key":"key20171206211924_b14","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1440-1746.2010.06384.x","article-title":"Population-based epidemiology study of autoimmune hepatitis: a disease of older women?","volume":"25","author":"Ngu","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"key20171206211924_b15","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/1751-2980.12085","article-title":"Autoimmune hepatitis in southern Israel: a 15-year multicenter study","volume":"14","author":"Delgado","year":"2013","journal-title":"J Dig Dis"},{"key":"key20171206211924_b16","doi-asserted-by":"crossref","first-page":"e0182391","DOI":"10.1371\/journal.pone.0182391","article-title":"Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"key":"key20171206211924_b17","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL Clinical Practice Guidelines: Autoimmune hepatitis","volume":"63","author":"European Association for the Study of the Liver","year":"2015","journal-title":"J Hepatol"},{"key":"key20171206211924_b18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1478-3231.2011.02734.x","article-title":"Hepatocellular carcinoma and survival in patients with autoimmune hepatitis (Japanese National Hospital Organization-autoimmune hepatitis prospective study)","volume":"32","author":"Migita","year":"2012","journal-title":"Liver Int"},{"key":"key20171206211924_b19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00535-011-0519-2","article-title":"Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1","volume":"47","author":"Hino-Arinaga","year":"2012","journal-title":"J Gastroenterol"},{"key":"key20171206211924_b20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00535-012-0616-x","article-title":"Clinical features of hepatocellular carcinoma in patients with autoimmune hepatitis in Japan","volume":"48","author":"Ohira","year":"2013","journal-title":"J Gastroenterol"},{"key":"key20171206211924_b21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5812\/hepatmon.4906","article-title":"Clinical features and long term outcome of 102 treated autoimmune hepatitis patients","volume":"12","author":"Malekzadeh","year":"2012","journal-title":"Hepat Mon"},{"key":"key20171206211924_b22","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/hep.25658","article-title":"Long-term outcome of Japanese patients with type 1 autoimmune hepatitis","volume":"56","author":"Yoshizawa","year":"2012","journal-title":"Hepatology"},{"key":"key20171206211924_b23","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/hep.26290","article-title":"Predictors of poor outcome in patients w ith autoimmune hepatitis: a population-based study","volume":"57","author":"Ngu","year":"2013","journal-title":"Hepatology"},{"key":"key20171206211924_b24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.gastro.2010.04.053","article-title":"Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis","volume":"139","author":"Czaja","year":"2010","journal-title":"Gastroenterology"},{"key":"key20171206211924_b25","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3748\/wjg.v7.i5.718","article-title":"Relationship between autoimmune hepatitis and HLA-DR4 and DRbeta allelic sequences in the third hypervariable region in Chinese","volume":"7","author":"Ma","year":"2001","journal-title":"World J Gastroenterol"},{"key":"key20171206211924_b26","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1007\/s10620-005-9068-y","article-title":"Type 1 autoimmune hepatitis in Taiwan: diagnosis using the revised criteria of the International Autoimmune Hepatitis Group","volume":"51","author":"Koay","year":"2006","journal-title":"Dig Dis Sci"},{"key":"key20171206211924_b27","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1007\/s10620-009-0995-x","article-title":"Association of HLA-DR14 with the treatment response in Japanese patients with autoimmune hepatitis","volume":"55","author":"Suzuki","year":"2010","journal-title":"Dig Dis Sci"},{"key":"key20171206211924_b28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12876-015-0360-9","article-title":"Evaluation of the role of HLA-DR antigens in Japanese type 1 autoimmune hepatitis","volume":"15","author":"Furumoto","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"key20171206211924_b29","first-page":"605","article-title":"Genetic distinctions and clinical characteristics of type 1 autoimmune hepatitis in Taiwan","volume":"55","author":"Huang","year":"2008","journal-title":"Hepatogastroenterology"},{"key":"key20171206211924_b30","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.bpg.2011.09.011","article-title":"Autoimmune hepatitis in special patient populations","volume":"25","author":"Czaja","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"key20171206211924_b31","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/hep.27983","article-title":"Prediction of short- and long-term outcome in patients with autoimmune hepatitis","volume":"62","author":"Kirstein","year":"2015","journal-title":"Hepatology"},{"key":"key20171206211924_b32","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0929-6646(08)60085-6","article-title":"Significant association of HLA-DQ5 with autoimmune hepatitis in Taiwan","volume":"106","author":"Koay","year":"2007","journal-title":"J Formos Med Assoc"},{"issue":"Suppl 5","key":"key20171206211924_b33","first-page":"S73","article-title":"Association between HLA class II alleles and autoimmune hepatitis type 1 in Thai patients","volume":"89","author":"Tanwandee","year":"2006","journal-title":"J Med Assoc Thai"},{"key":"key20171206211924_b34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1440-1746.2004.03608.x","article-title":"Human leukocyte antigen allele associations in type-1 autoimmune hepatitis patients from western India","volume":"20","author":"Shankarkumar","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"key20171206211924_b35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jceh.2013.12.002","article-title":"HLA DRB1 Alleles Discriminate the Manifestation of Autoimmune Hepatitis as Type 1 or Type 2 in North Indian Population","volume":"4","author":"Kaur","year":"2014","journal-title":"J Clin Exp Hepatol"},{"key":"key20171206211924_b36","doi-asserted-by":"crossref","first-page":"e13598","DOI":"10.5812\/hepatmon.13598","article-title":"Clinical profile and HLA typing of autoimmune hepatitis from Pakistan","volume":"13","author":"Hassan","year":"2013","journal-title":"Hepat Mon"},{"key":"key20171206211924_b37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaut.2015.10.006","article-title":"The clinical phenotypes of autoimmune hepatitis: A comprehensive review","volume":"66","author":"Wang","year":"2016","journal-title":"J Autoimmun"},{"key":"key20171206211924_b38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004836-200207000-00016","article-title":"Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients","volume":"35","author":"Kogan","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"key20171206211924_b39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatology"},{"key":"key20171206211924_b40","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/hep.23840","article-title":"Treatment response in patients with autoimmune hepatitis","volume":"52","author":"Schramm","year":"2010","journal-title":"Hepatology"},{"key":"key20171206211924_b41","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2014.10.018","article-title":"Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis","volume":"62","author":"Hartl","year":"2015","journal-title":"J Hepatol"},{"key":"key20171206211924_b42","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2006.04.007","article-title":"Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre","volume":"45","author":"Al-Chalabi","year":"2006","journal-title":"J Hepatol"},{"key":"key20171206211924_b43","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/0016-5085(93)91081-R","article-title":"Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"key20171206211924_b44","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12016-014-8432-0","article-title":"Emperipolesis mediated by CD8 T cells is a characteristic histopathologic feature of autoimmune hepatitis","volume":"48","author":"Miao","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"key20171206211924_b45","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1055\/s-0029-1233532","article-title":"Scoring systems for the diagnosis of autoimmune hepatitis: past, present, and future","volume":"29","author":"Wiegard","year":"2009","journal-title":"Semin Liver Dis"},{"key":"key20171206211924_b46","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1478-3231.2011.02524.x","article-title":"Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group criteria in acute-onset autoimmune hepatitis","volume":"31","author":"Fujiwara","year":"2011","journal-title":"Liver Int"},{"key":"key20171206211924_b47","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1440-1746.2012.07292.x","article-title":"Clinical features of autoimmune hepatitis and comparison of two diagnostic criteria in Korea: a nationwide, multicenter study","volume":"28","author":"Kim","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"key20171206211924_b48","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s12072-016-9767-9","article-title":"Autoimmune liver diseases in the Asia-Pacific region: Proceedings of APASL symposium on AIH and PBC 2016","volume":"10","author":"Tanaka","year":"2016","journal-title":"Hepatol Int"},{"key":"key20171206211924_b49","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/jgh.13508","article-title":"Evaluation of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis","volume":"32","author":"Xu","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"key20171206211924_b50","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"key20171206211924_b51","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/gut.2010.235259","article-title":"British Society of Gastroenterology. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis","volume":"60","author":"Gleeson","year":"2011","journal-title":"Gut"},{"key":"key20171206211924_b52","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2015.03.005","article-title":"Autoimmune hepatitis\u2013Update 2015","volume":"62","author":"Manns","year":"2015","journal-title":"J Hepatol"},{"key":"key20171206211924_b53","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7869\/tg.243","article-title":"Autoimmune hepatitis in India: single tertiary referral centre experience","volume":"36","author":"Amarapurkar","year":"2015","journal-title":"Trop Gastroenterol"},{"key":"key20171206211924_b54","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2036.2011.04690.x","article-title":"Early normalisation of aminotransferase predicts complete biochemical remission in autoimmune hepatitis patients","volume":"34","author":"Wang","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"key20171206211924_b55","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cgh.2015.09.037","article-title":"Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine Intolerance","volume":"14","author":"H\u00fcbener","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20171206211924_b56","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.autrev.2011.09.006","article-title":"Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome","volume":"11","author":"Efe","year":"2012","journal-title":"Autoimmun Rev"},{"key":"key20171206211924_b57","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1007\/s10620-011-1789-5","article-title":"Efficacy of intravenous glycyrrhizin in the early stage of acute onset autoimmune hepatitis","volume":"56","author":"Yasui","year":"2011","journal-title":"Dig Dis Sci"},{"key":"key20171206211924_b58","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1155\/2010\/891252","article-title":"Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy","volume":"24","author":"Sharzehi","year":"2010","journal-title":"Can J Gastroenterol"},{"key":"key20171206211924_b59","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jhep.2010.12.032","article-title":"Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-na\u00efve patients","volume":"55","author":"Zachou","year":"2011","journal-title":"J Hepatol"},{"key":"key20171206211924_b60","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0168-8278(05)80615-4","article-title":"Cyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatitis","volume":"21","author":"Sherman","year":"1994","journal-title":"J Hepatol"},{"key":"key20171206211924_b61","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1572-0241.1999.00807.x","article-title":"Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis","volume":"94","author":"Fernandes","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"key20171206211924_b62","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.3748\/wjg.v13.i23.3232","article-title":"Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis","volume":"13","author":"Larsen","year":"2007","journal-title":"World J Gastroenterol"},{"key":"key20171206211924_b63","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2036.2011.04749.x","article-title":"Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experience","volume":"34","author":"Tannous","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"key20171206211924_b64","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2012.11.010","article-title":"Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis","volume":"58","author":"Weiler-Normann","year":"2013","journal-title":"J Hepatol"},{"key":"key20171206211924_b65","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/00365521.2015.1095351","article-title":"Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy","volume":"51","author":"Than","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"key20171206211924_b66","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/apt.13907","article-title":"Expert clinical management of autoimmune hepatitis in the real world","volume":"45","author":"Liberal","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"key20171206211924_b67","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1053\/j.gastro.2012.02.041","article-title":"Inhibition of interleukin-17 promotes differentiation of CD25\u2212 cells into stable T regulatory cells in patients with autoimmune hepatitis","volume":"142","author":"Longhi","year":"2012","journal-title":"Gastroenterology"},{"key":"key20171206211924_b68","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2013.06.016","article-title":"The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies","volume":"46","author":"Muratori","year":"2013","journal-title":"J Autoimmun"},{"key":"key20171206211924_b69","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2014.02.010","article-title":"The critical role of myeloid-derived suppressor cells and FXR activation in immune-mediated liver injury","volume":"53","author":"Zhang","year":"2014","journal-title":"J Autoimmun"},{"key":"key20171206211924_b70","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/hepr.12397","article-title":"Rapid corticosteroid tapering: Important risk factor for type 1 autoimmune hepatitis relapse in Japan","volume":"45","author":"Takahashi","year":"2015","journal-title":"Hepatol Res"},{"key":"key20171206211924_b71","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1872-034X.2011.00812.x","article-title":"Risk factors associated with relapse of type 1 autoimmune hepatitis in Japan","volume":"41","author":"Yokokawa","year":"2011","journal-title":"Hepatol Res"},{"key":"key20171206211924_b72","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.transproceed.2017.03.014","article-title":"Comparative analysis of the clinical outcomes of liver transplantation for probable and definite auto-immune hepatitis by international diagnostic scoring criteria","volume":"49","author":"Cho","year":"2017","journal-title":"Transplant Proc"},{"key":"key20171206211924_b73","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1872-034X.2012.01109.x","article-title":"Prognosis of autoimmune hepatitis showing acute presentation","volume":"43","author":"Yamamoto","year":"2013","journal-title":"Hepatol Res"},{"key":"key20171206211924_b74","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s00535-011-0421-y","article-title":"Present status of autoimmune hepatitis in Japan: a nationwide survey","volume":"46","author":"Abe","year":"2011","journal-title":"J Gastroenterol"},{"key":"key20171206211924_b75","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.dld.2009.04.009","article-title":"Autoimmune hepatitis with acute presentation in Japan","volume":"42","author":"Miyake","year":"2010","journal-title":"Dig Liver Dis"},{"key":"key20171206211924_b76","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4254\/wjh.v4.i9.262","article-title":"Centrilobular necrosis in acute presentation of Japanese patients with type 1 autoimmune hepatitis","volume":"4","author":"Abe","year":"2012","journal-title":"World J Hepatol"},{"key":"key20171206211924_b77","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1872-034X.2008.00347.x","article-title":"Comparison of clinical features and liver histology in acute and chronic autoimmune hepatitis","volume":"38","author":"Iwai","year":"2008","journal-title":"Hepatol Res"},{"key":"key20171206211924_b78","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2014.06.030","article-title":"Acute autoimmune hepatitis: many open questions","volume":"61","author":"Weiler-Normann","year":"2014","journal-title":"J Hepatol"},{"key":"key20171206211924_b79","first-page":"69","article-title":"A preliminary open trial on interferon stimulator (SNMC) derived from Glycyrrhiza glabra in the treatment of subacute hepatic failure","volume":"98","author":"Acharya","year":"1993","journal-title":"Indian J Med Res"},{"key":"key20171206211924_b80","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1386-6346(01)00155-3","article-title":"Clinical spectrum of acute sporadic hepatitis E and possible benefit of glycyrrhizin therapy","volume":"23","author":"Tandon","year":"2002","journal-title":"Hepatol Res"},{"key":"key20171206211924_b81","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.3748\/wjg.v20.i23.7473","article-title":"Clinical characteristics and corticosteroid therapy in patients with autoimmune-hepatitis-induced liver failure","volume":"20","author":"Zhu","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key20171206211924_b82","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cgh.2006.10.011","article-title":"Clinicopathologic features of the severe form of acute type 1 autoimmune hepatitis","volume":"5","author":"Abe","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20171206211924_b83","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/lt.21088","article-title":"Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: therapeutic brinksmanship and the point beyond salvation","volume":"13","author":"Czaja","year":"2007","journal-title":"Liver Transpl"},{"key":"key20171206211924_b84","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1872-034X.2008.00329.x","article-title":"A model for estimating cirrhosis in patients with type 1 autoimmune hepatitis","volume":"38","author":"Miyake","year":"2008","journal-title":"Hepatol Res"},{"key":"key20171206211924_b85","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.2169\/internalmedicine.51.8372","article-title":"Clinical features of cirrhosis in Japanese patients with type I autoimmune hepatitis","volume":"51","author":"Abe","year":"2012","journal-title":"Intern Med"},{"key":"key20171206211924_b86","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N Engl J Med"},{"key":"key20171206211924_b87","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/gut.16.11.876","article-title":"Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared","volume":"16","author":"Summerskill","year":"1975","journal-title":"Gut"},{"key":"key20171206211924_b88","first-page":"331","article-title":"Prednisone for chronic active hepatitis: pharmacokinetics and serum binding in patients with chronic active hepatitis and steroid major side effects","volume":"6","author":"Uribe","year":"1984","journal-title":"J Clin Gastroenterol"},{"key":"key20171206211924_b89","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s10620-006-9336-5","article-title":"Thiopurine methyltransferase deficiency and azathioprine intolerance in autoimmune hepatitis","volume":"51","author":"Czaja","year":"2006","journal-title":"Dig Dis Sci"},{"key":"key20171206211924_b90","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2006.05.011","article-title":"Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis","volume":"45","author":"Heneghan","year":"2006","journal-title":"J Hepatol"},{"key":"key20171206211924_b91","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12016-016-8583-2","article-title":"The management of autoimmune hepatitis patients with decompensated cirrhosis: real-world experience and a comprehensive review","volume":"52","author":"Wang","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"key20171206211924_b92","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/apt.12470","article-title":"Review article: autoimmune hepatitis \u2013 current management and challenges","volume":"38","author":"Zachou","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"key20171206211924_b93","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.22432","article-title":"Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening","volume":"48","author":"Yeoman","year":"2008","journal-title":"Hepatology"},{"key":"key20171206211924_b94","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2013.08.004","article-title":"Autoimmune hepatitis: Contrasts and comparisons in children and adults - a comprehensive review","volume":"46","author":"Floreani","year":"2013","journal-title":"J Autoimmun"},{"key":"key20171206211924_b95","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s10620-006-9665-4","article-title":"Corticosteroid-responsive cryptogenic chronic hepatitis: evidence for seronegative autoimmune hepatitis","volume":"52","author":"Gassert","year":"2007","journal-title":"Dig Dis Sci"},{"key":"key20171206211924_b96","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1872-034X.2008.00454.x","article-title":"Clinical features of antinuclear antibodies-negative type 1 autoimmune hepatitis","volume":"39","author":"Miyake","year":"2009","journal-title":"Hepatol Res"},{"key":"key20171206211924_b97","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/1751-2980.12022","article-title":"Clinical and histological features of autoantibody-negative autoimmune hepatitis in Chinese patients: a single center experience","volume":"14","author":"Wang","year":"2013","journal-title":"J Dig Dis"},{"key":"key20171206211924_b98","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1478-3231.2011.02487.x","article-title":"Identification of T cell epitopes on soluble liver antigen in Chinese patients with auto-immune hepatitis","volume":"31","author":"Zhao","year":"2011","journal-title":"Liver Int"},{"key":"key20171206211924_b99","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1055\/s-0034-1383732","article-title":"Clinical significance of autoantibodies in primary biliary cirrhosis","volume":"34","author":"Nakamura","year":"2014","journal-title":"Semin Liver Dis"},{"key":"key20171206211924_b100","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1872-034X.2010.00684.x","article-title":"Clinical characteristics of patients with autoimmune hepatitis seropositive for anticentromere antibody","volume":"40","author":"Himoto","year":"2010","journal-title":"Hepatol Res"},{"key":"key20171206211924_b101","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2007.08.013","article-title":"Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis","volume":"48","author":"Al-Chalabi","year":"2008","journal-title":"J Hepatol"},{"key":"key20171206211924_b102","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/hep.24141","article-title":"Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis","volume":"53","author":"Yeoman","year":"2011","journal-title":"Hepatology"},{"key":"key20171206211924_b103","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1111\/j.1572-0241.2008.02180.x","article-title":"Mycophenolate mofetil as second line therapy in autoimmune hepatitis?","volume":"103","author":"Hennes","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"key20171206211924_b104","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J Hepatol"},{"key":"key20171206211924_b105","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouill\u00e8res","year":"1998","journal-title":"Hepatology"},{"key":"key20171206211924_b106","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaut.2012.10.004","article-title":"Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis","volume":"41","author":"Wang","year":"2013","journal-title":"J Autoimmun"},{"key":"key20171206211924_b107","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12016-015-8516-5","article-title":"The natural history and prognosis of primary biliary cirrhosis with clinical features of autoimmune hepatitis","volume":"50","author":"Yang","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"key20171206211924_b108","first-page":"148","article-title":"A meta-analysis of ursodeoxycholic acid therapy versus combination therapy with corticosteroids for PBC-AIH-overlap syndrome: evidence from 97 monotherapy and 117 combinations","volume":"10","author":"Zhang","year":"2015","journal-title":"Prz Gastroenterol"},{"key":"key20171206211924_b109","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1872-034X.2011.00844.x","article-title":"Primary biliary cirrhosis - Autoimmune hepatitis overlap syndrome: A rationale for corticosteroids use based on a nation-wide retrospective study in Japan","volume":"41","author":"Tanaka","year":"2011","journal-title":"Hepatol Res"},{"key":"key20171206211924_b110","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1023\/B:DDAS.0000004522.36120.08","article-title":"Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates","volume":"48","author":"Loria","year":"2003","journal-title":"Dig Dis Sci"},{"key":"key20171206211924_b111","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/01.mcg.0000139072.38580.a0","article-title":"Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis","volume":"38","author":"Cotler","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"key20171206211924_b112","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1159\/000332152","article-title":"Histological remission during corticosteroid therapy of overlapping nonalcoholic steatohepatitis and autoimmune hepatitis: case report and literature review","volume":"5","author":"Fukuda","year":"2011","journal-title":"Case Rep Gastroenterol"},{"key":"key20171206211924_b113","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/jvh.12302","article-title":"Low prevalence of hepatitis B virus infection in patients with autoimmune diseases in a Chinese patient population","volume":"21","author":"Sui","year":"2014","journal-title":"J Viral Hepat"},{"key":"key20171206211924_b114","volume-title":"WHO Guidelines Approved by the Guidelines Review Committee","author":"Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection","year":"2015"},{"key":"key20171206211924_b115","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/jvh.12428","article-title":"T- and B-cell responses and previous exposure to hepatitis B virus in \u2018anti-HBc alone\u2019 patients","volume":"22","author":"Wang","year":"2015","journal-title":"J Viral Hepat"},{"key":"key20171206211924_b116","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1136\/gut.2007.122283","article-title":"IgG4 associated autoimmune hepatitis: a differential diagnosis for classical autoimmune hepatitis","volume":"56","author":"Umemura","year":"2007","journal-title":"Gut"},{"issue":"Suppl 1","key":"key20171206211924_b117","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00535-010-0323-4","article-title":"Clinical significance of immunoglobulin G4-associated autoimmune hepatitis","volume":"46","author":"Umemura","year":"2011","journal-title":"J Gastroenterol"},{"key":"key20171206211924_b118","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1478-3231.2009.02092.x","article-title":"Identification and characterization of IgG4-associated autoimmune hepatitis","volume":"30","author":"Chung","year":"2010","journal-title":"Liver Int"},{"key":"key20171206211924_b119","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.transproceed.2012.02.049","article-title":"Immunoglobulin G4-associated de novo autoimmune hepatitis after liver transplantation for chronic hepatitis B- and C-related cirrhosis and hepatocellular carcinoma: a case report with literature review","volume":"45","author":"Zhao","year":"2013","journal-title":"Transplant Proc"}],"container-title":["Journal of Clinical and Translational Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.xiahepublishing.com\/ArticleFullText.aspx?sid=2&jid=1&id=10.14218%2fJCTH.2017.00032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:16:58Z","timestamp":1783707418000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.xiahepublishing.com\/ArticleFullText.aspx?sid=2&jid=1&id=10.14218%2fJCTH.2017.00032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,7]]},"references-count":119,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12,7]]},"published-print":{"date-parts":[[2018,3,28]]}},"alternative-id":["10.14218\/JCTH.2017.00032"],"URL":"https:\/\/doi.org\/10.14218\/jcth.2017.00032","relation":{},"ISSN":["2225-0719","2310-8819"],"issn-type":[{"value":"2225-0719","type":"print"},{"value":"2310-8819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,7]]}}}